Don’t Forget HPV-45 in Cervical Cancer ScreeningThe Authors’ Reply

High-Risk Human Papillomavirus Testing in Women With ASC-US Cytology

(2011) Mark H. Stoler et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: Extended follow up in the ARTISTIC trial

(2011) Henry C. Kitchener et al.   EUROPEAN JOURNAL OF CANCER

Long-term Absolute Risk of Cervical Intraepithelial Neoplasia Grade 3 or Worse Following Human Papillomavirus Infection: Role of Persistence

(2010) S. K. Kjaer et al.   JNCI-Journal of the National Cancer Institute

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

(2010) Silvia de Sanjose et al.   LANCET ONCOLOGY

Detection of Precancerous Cervical Lesions Is Differential by Human Papillomavirus Type

(2009) M. Safaeian et al.   CANCER RESEARCH

Type-Dependent Integration Frequency of Human Papillomavirus Genomes in Cervical Lesions

(2008) S. Vinokurova et al.   CANCER RESEARCH

Epidemiology and Natural History of Human Papillomavirus Infections and Type-Specific Implications in Cervical Neoplasia

(2008) F. Xavier Bosch et al.   VACCINE